Truist Financial Corp Grows Stock Position in Stevanato Group S.p.A. $STVN

Truist Financial Corp raised its position in Stevanato Group S.p.A. (NYSE:STVN) by 9.5% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,029 shares of the company’s stock after purchasing an additional 2,781 shares during the quarter. Truist Financial Corp’s holdings in Stevanato Group were worth $782,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Whittier Trust Co. acquired a new stake in Stevanato Group during the 1st quarter worth approximately $27,000. Twin Tree Management LP acquired a new stake in Stevanato Group during the 1st quarter valued at approximately $29,000. SVB Wealth LLC acquired a new position in shares of Stevanato Group in the 1st quarter worth approximately $46,000. Van Berkom & Associates Inc. grew its position in shares of Stevanato Group by 33.3% in the 1st quarter. Van Berkom & Associates Inc. now owns 2,400 shares of the company’s stock worth $49,000 after acquiring an additional 600 shares in the last quarter. Finally, PNC Financial Services Group Inc. grew its position in shares of Stevanato Group by 62.4% in the 1st quarter. PNC Financial Services Group Inc. now owns 9,182 shares of the company’s stock worth $187,000 after acquiring an additional 3,528 shares in the last quarter.

Stevanato Group Trading Up 3.8%

NYSE:STVN opened at €24.19 on Wednesday. Stevanato Group S.p.A. has a 12-month low of €17.12 and a 12-month high of €28.00. The firm has a market capitalization of $7.33 billion, a P/E ratio of 44.80, a P/E/G ratio of 2.19 and a beta of 0.57. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.79 and a quick ratio of 1.22. The business has a 50 day simple moving average of €24.43 and a 200 day simple moving average of €23.62.

Analyst Ratings Changes

Several research analysts have recently commented on the company. William Blair reiterated an “outperform” rating on shares of Stevanato Group in a research report on Monday, June 30th. Weiss Ratings reiterated a “hold (c)” rating on shares of Stevanato Group in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy”.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.